DOI: 10.1055/s-00000054

Pharmacopsychiatry

Issue 02 · Volume 29 · March 1996 DOI: 10.1055/s-002-6371

Original Paper

  • 47
    Kanowski, S.; Herrmann, W. M.; Stephan, K.; Wierich, W.; Hörr, R.:

    Proof of Efficacy of the Ginkgo Biloba Special Extract EGb 761 in Outpatients Suffering from Mild to Moderate Primary Degenerative Dementia of the Alzheimer Type or Multi-infarct Dementia

  • 57
    Möller, H.-J.; Müller, H.; Volz, H.-P.:

    How to Assess the Onset of Antidepressant Effect: Comparison of Global Ratings and Findings Based on Depression Scales

  • 63
    Modell, S.; Naber, D.; Holzbach, R.:

    Efficacy and Safety of an Opiate Sigma-Receptor Antagonist (SL 82.0715) in Schizophrenic Patients with Negative Symptoms: an Open Dose-Range Study

  • 67
    Hillert, A.; Sandmann, J.; Ehmig, S. C.; Sobota, K.; Weisbecker, W.; Kepplinger, H. M.; Benkert, O.:

    Psychopharmacological Drugs as Represented in the Press: Results of Systematic Analysis of Newspapers and Popular Magazines

  • 72
    Gründer, G.; Wetzel, H.; Schlößer, R.; Benkert, O.:

    Subchronic Antidepressant Treatment with Venlafaxine or Imipramine and Effects on Blood Pressure and Heart Rate: Assessment by Automatic 24-Hour Monitoring

    • Case Report

  • 79
    Ilan, Y.; Samuel, D.; Reynes, M.; Tur-Kaspa, Ran:

    Hepatic Failure Associated with Imipramine Therapy

    • Letter to the Editor

  • 81
    Hoes, M. J. A. J. M.:

    Mirtazapine as Treatment for Serotonin Syndrome